Company: BSX
Filing Date: 2025-02-18
Form Type: S-3ASR
Source: 0001104659-25-014808
Chunk: 20

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: S-3ASR
Chunk 20
---
 and amendments to the indenture may be made by Boston Scientific, any applicable issuer, any applicable guarantor and the trustee with the consent of Holders of not less than a majority in principal amount of the outstanding debt securities of each series issued under the indenture that is affected by the modification or amendment; provided , however , that no such modification or amendment may, without the consent of the Holder of each outstanding debt security affected thereby:

(1)

change the Stated Maturity (as defined in the indenture) of the principal of (or premium, if any) or any installment of interest on any debt security of that series, or reduce the principal amount thereof (or premium, if any) or the rate of interest, if any, thereon, or change any of the applicable issuer’s obligations to pay Additional Amounts (except as contemplated or permitted by the

<div align='center'>12</div>

TABLE OF CONTENTS

indenture), or reduce the amount of principal of an Original Issue Discount Security (as defined in the indenture) of that series that would be due and payable upon a declaration of acceleration of the maturity thereof or the amount thereof provable in bankruptcy, or adversely affect any right of repayment at the option of any Holder of any debt security of such series, or change any place of payment where, or the currency in which, any debt security of that series or any premium or interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption or repayment at the option of the Holder, on or after the redemption date or repayment date, as the case may be), or adversely affect any right to convert or exchange any debt security;

(2)

reduce the percentage in principal amount of the outstanding debt securities of any series, the consent of whose Holders is required for any supplemental indenture, for any waiver of compliance with certain provisions of the indenture that affect such series or certain defaults applicable to that series thereunder and their consequences provided for in the indenture, or reduce the quorum or voting with respect to debt securities of that series;

(3)

release any guarantor from its obligations in respect of the guarantee of any series of debt securities affected or modify the guarantee of any series of debt securities in any manner materially adverse to Holders of that series; or

(4)

modify any of the provisions relating to supplemental indentures requiring the consent of Holders or relating to the